Lookout for Severe Joint Pain with Gliptins

A new FDA warning will spur questions about whether gliptins (sitagliptin, saxagliptin, etc) cause severe joint pain.

This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling and lead to hospitalization.

We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4)...an enzyme that breaks down incretin hormones.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote